Tag: opioid labeling changes

item-image
May, 6 2026

FDA Drug Safety Communications and Recalls: What Patients and Prescribers Need to Know in 2026

Explore recent FDA Drug Safety Communications and medication recalls impacting patients in 2026. Learn about critical updates for opioids, Leqembi, ADHD stimulants, and mRNA vaccines, and understand how to navigate these new safety protocols.